Type-I-interferons in infection and cancer: Unanticipated dynamics with therapeutic implications
If there is a great new hope in the treatment of cancer, the immune system is it. Innate and adaptive immunity either promote or attenuate tumorigenesis and so can have opposing effects on the therapeutic outcome. Originally described as potent antivirals, Type-I interferons (IFNs) were quickly reco...
Main Authors: | Martina Musella, Gwenola Manic, Ruggero De Maria, Ilio Vitale, Antonella Sistigu |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-05-01
|
Series: | OncoImmunology |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/2162402X.2017.1314424 |
Similar Items
-
The Immune Privilege of Cancer Stem Cells: A Key to Understanding Tumor Immune Escape and Therapy Failure
by: Claudia Galassi, et al.
Published: (2021-09-01) -
Tuning Cancer Fate: Tumor Microenvironment's Role in Cancer Stem Cell Quiescence and Reawakening
by: Antonella Sistigu, et al.
Published: (2020-10-01) -
Interferon gamma in cancer immunotherapy
by: Ling Ni, et al.
Published: (2018-09-01) -
Actin Cytoskeleton Dynamics and Type I IFN-Mediated Immune Response: A Dangerous Liaison in Cancer?
by: Paola Trono, et al.
Published: (2021-09-01) -
Domatinostat favors the immunotherapy response by modulating the tumor immune microenvironment (TIME)
by: Anne Catherine Bretz, et al.
Published: (2019-11-01)